{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:41:12Z","timestamp":1791254472618,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.pt.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T13:05:49Z","timestamp":1378731949000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":232,"title":["Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria"],"prefix":"10.1016","volume":"29","author":[{"given":"Inbarani","family":"Naidoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cally","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2013.08.002_bib0005","series-title":"World Health Organisation Policy Recommendation on Intermittent Preventive Treatment during Infancy with Sulphadoxine-Pyrimethamine (SP-IPTi) for Plasmodium falciparum Malaria Control in Africa","author":"World Health and Organisation","year":"2010"},{"key":"10.1016\/j.pt.2013.08.002_bib0010","series-title":"World Health Organisation Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum Malaria Control in Highly Seasonal Transmission Areas of the Sahel sub-region in Africa","author":"World Health and Organisation","year":"2012"},{"key":"10.1016\/j.pt.2013.08.002_bib0015","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.08.002_bib0020","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1073\/pnas.85.23.9109","article-title":"Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum","volume":"85","author":"Cowman","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.08.002_bib0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1432-1033.1994.00397.x","article-title":"Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine","volume":"224","author":"Brooks","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pt.2013.08.002_bib0030","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.91.15.7149","article-title":"Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum","volume":"91","author":"Triglia","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.08.002_bib0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"Roper","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pt.2013.08.002_bib0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/588198","article-title":"Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987\u20132006","volume":"197","author":"Certain","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/518512","article-title":"A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa","volume":"196","author":"Maiga","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/00034980120103234","article-title":"Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area","volume":"95","author":"Omar","year":"2001","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.pt.2013.08.002_bib0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-3156.2004.01239.x","article-title":"Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda","volume":"9","author":"Staedke","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/338566","article-title":"Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria","volume":"185","author":"Kublin","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0065","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","article-title":"Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review","volume":"297","author":"ter Kuile","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.pt.2013.08.002_bib0070","series-title":"Technical Expert Group Meeting on Intermittent Preventive Treatment in Pregnancy (IPTp), 11\u201313 July, 2007","author":"World Health and Organisation","year":"2007"},{"key":"10.1016\/j.pt.2013.08.002_bib0075","doi-asserted-by":"crossref","first-page":"e4569","DOI":"10.1371\/journal.pone.0004569","article-title":"High resistance of Plasmodium falciparum to sulphadoxine\/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at codon 581","volume":"4","author":"Gesase","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2013.08.002_bib0080","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1073\/pnas.0901415106","article-title":"Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment","volume":"106","author":"Harrington","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.08.002_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4269\/ajtmh.2009.80.523","article-title":"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene","volume":"80","author":"Alifrangis","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0090","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(09)60997-1","article-title":"Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Gosling","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2013.08.002_bib0095","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0035-9203(97)90284-4","article-title":"Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya","volume":"91","author":"Khan","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0166-6851(97)00114-X","article-title":"Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins","volume":"89","author":"Wang","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.08.002_bib0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1999.61.125","article-title":"Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children","volume":"61","author":"Jelinek","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-3156.2005.01471.x","article-title":"Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana","volume":"10","author":"Mockenhaupt","year":"2005","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00436-005-1424-5","article-title":"Malaria cure with sulphadoxine\/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes","volume":"97","author":"Berzosa","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2013.08.002_bib0120","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-3156.2005.01415.x","article-title":"The role of sequential administration of sulphadoxine\/pyrimethamine following quinine in the treatment of severe falciparum malaria in children","volume":"10","author":"Ogutu","year":"2005","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1475-2875-7-236","article-title":"Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola","volume":"7","author":"Figueiredo","year":"2008","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0130","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/AAC.00610-09","article-title":"Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility","volume":"53","author":"Andriantsoanirina","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2013.08.002_bib0135","first-page":"461","article-title":"Molecular monitoring of falciparum malaria isolates in C\u00f4te d\u2019Ivoire: genetic markers for antimalarial drugs","volume":"40","author":"Djaman","year":"2010","journal-title":"Eur. J. Sci. Res."},{"key":"10.1016\/j.pt.2013.08.002_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2875-8-32","article-title":"Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR\/RFLP in Niger","volume":"8","author":"Ibrahim","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.actatropica.2005.06.015","article-title":"Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria","volume":"95","author":"Happi","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2013.08.002_bib0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4269\/ajtmh.2008.78.455","article-title":"Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali","volume":"78","author":"Djimde","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.2006.75.162","article-title":"Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso","volume":"75","author":"Dokomajilar","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2875-10-22","article-title":"Evaluation of prevalences of pfdhfr and pfdhps mutations in Angola","volume":"10","author":"Fortes","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4269\/ajtmh.2005.73.1131","article-title":"Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia","volume":"73","author":"Gebru-Woldearegai","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.meegid.2009.04.015","article-title":"Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya","volume":"9","author":"Bonizzoni","year":"2009","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.pt.2013.08.002_bib0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.actatropica.2007.04.006","article-title":"Molecular surveillance for drug-resistant Plasmodium falciparum malaria in Malawi","volume":"102","author":"Nkhoma","year":"2007","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2013.08.002_bib0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2334-10-163","article-title":"Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparum","volume":"10","author":"Salgueiro","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0185","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/587845","article-title":"Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda","volume":"197","author":"Lynch","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2875-5-54","article-title":"High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia","volume":"5","author":"Schunk","year":"2006","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0195","doi-asserted-by":"crossref","first-page":"e4364","DOI":"10.1371\/journal.pone.0004364","article-title":"Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya","volume":"4","author":"Oesterholt","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2013.08.002_bib0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2334-8-105","article-title":"Molecular epidemiology of drug-resistant malaria in western Kenya highlands","volume":"8","author":"Zhong","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/AAC.00498-09","article-title":"Molecular correlates of high level antifolate resistance in Rwandan children with Plasmodium falciparum malaria","volume":"54","author":"Karema","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2013.08.002_bib0210","doi-asserted-by":"crossref","first-page":"e1000055","DOI":"10.1371\/journal.pmed.1000055","article-title":"Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria","volume":"6","author":"Pearce","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2013.08.002_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-9-9","article-title":"Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali","volume":"9","author":"Dicko","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.2006.74.205","article-title":"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic","volume":"74","author":"Menard","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0225","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1365-3156.2008.02150.x","article-title":"dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo","volume":"13","author":"Alker","year":"2008","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4269\/ajtmh.2006.75.152","article-title":"Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo","volume":"75","author":"Cohuet","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0235","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1365-3156.2006.01710.x","article-title":"Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes","volume":"11","author":"Swarthout","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4269\/ajtmh.2009.80.555","article-title":"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo","volume":"80","author":"Mobula","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1475-2875-6-108","article-title":"The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics","volume":"6","author":"A-Elbasit","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1475-2875-9-338","article-title":"Increased prevalence of the pfdhfr\/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya","volume":"9","author":"Spalding","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.trstmh.2008.01.018","article-title":"Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation","volume":"102","author":"Hamel","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2013.08.002_bib0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1086\/504687","article-title":"Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles","volume":"194","author":"McCollum","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0265","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1475-2875-9-190","article-title":"Drug coverage in treatment of malaria and the consequences for resistance evolution \u2013 evidence from the use of sulphadoxine\/pyrimethamine","volume":"9","author":"Malisa","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2013.08.002_bib0270","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1371\/journal.pone.0000139","article-title":"Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use","volume":"2","author":"Noranate","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2013.08.002_bib0275","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1017\/S0031182011000746","article-title":"Drug resistance maps to guide intermittent preventive treatment of malaria in African infants","volume":"138","author":"Naidoo","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2013.08.002_bib0280","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.43.9.2205","article-title":"Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains","volume":"43","author":"Kun","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2013.08.002_bib0285","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.pctr.0010014","article-title":"Randomised trial of chloroquine\/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum","volume":"1","author":"Dunyo","year":"2006","journal-title":"PLoS Clin. Trials"},{"key":"10.1016\/j.pt.2013.08.002_bib0290","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-3156.2007.01904.x","article-title":"Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo","volume":"12","author":"Ndounga","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0295","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.08.002_bib0300","doi-asserted-by":"crossref","first-page":"e12618","DOI":"10.1371\/journal.pone.0012618","article-title":"Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance","volume":"5","author":"Griffin","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2013.08.002_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2013.07.008","article-title":"Monitoring antifolate resistance in intermittent preventive therapy for malaria","author":"Venkatesan","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2013.08.002_bib0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cid\/cir374","article-title":"Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in Mali: a randomized controlled trial","volume":"53","author":"Diakite","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0315","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-3156.2011.02935.x","article-title":"Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC)","volume":"17","author":"Likwela","year":"2012","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2013.08.002_bib0320","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S1473-3099(12)70241-4","article-title":"Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems","volume":"12","author":"Talisuna","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2013.08.002_bib0325","series-title":"WHO Global Malaria Programme World Malaria Report","author":"World Health and Organisation","year":"2011"},{"key":"10.1016\/j.pt.2013.08.002_bib0330","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1473-3099(10)70295-4","article-title":"Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data","volume":"11","author":"van Eijk","year":"2011","journal-title":"Lancet Infect. Dis."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492213001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492213001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:17:40Z","timestamp":1715969860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492213001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1471492213001360"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2013.08.002","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}